Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Public vs Private Company
private does nothing for us. not that it matters if you see the advantages of how Neo fits into PTSC, hopefully Pohl and Turley see. Neo is struggling to stay alive with a huge amount of intellectual property and unrealized potential. They have a product that could be combined with the Ignite. They have established sales connections. They have a low number of shares outstanding. Neo shareholders would receive some new shares of the new company and we have the chance to get off of BB. Of course we would have to have enough revenue to keep that share price on the big board.
Share
New Message
Please login to post a reply